About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Molecular Pathway may Predict Chemotherapy Effectiveness in Lung Cancer Patients

by VR Sreeraman on September 2, 2007 at 12:30 PM
Font : A-A+

Molecular Pathway may Predict Chemotherapy Effectiveness in Lung Cancer Patients

A new research has found that physicians might be able predict which lung cancer patients will gain from chemotherapy drugs, through a common molecular pathway.

Known as the retinoblastoma (RB) tumor suppressor, this essential molecule regulates cell proliferation in the body. Research has shown that the RB pathway is either entirely inactive or altered in most human cancers. Scientists are beginning to use its actions as a "biomarker" for how tumors will respond to different therapies.

Advertisement

A multidisciplinary team at the University of Cincinnati found that "turning off" the RB pathway in lung cancer cells resulted in an altered response to chemotherapy agents and more cancer cell death.

"Dissecting the RB pathway will help us better understand how chemotherapy works and predict which patients might benefit from therapy and which ones won't," explains Michael Reed, lead author and assistant professor of surgery at UC and a thoracic surgeon at University Hospital.
Advertisement

"As pathways are further defined, we could choose agents that are targeted to an individual tumor's molecular characteristics," he adds.

For this laboratory study, Reed's team shut off the RB pathway in human non-small cell lung cancer cells and exposed them to chemotherapy agents representative of those currently used to treat lung cancer patients.

Their results showed that when RB was turned off, the cancer cells continued to divide, but became more vulnerable to the drugs, so the tumours stopped growing.

"But the minute you take away the chemotherapy, the cells take off again. This suggests that it's not just loss of RB that affects therapy response—it could be changes at various steps in cellular signaling that result in different outcomes," says Reed.

"The traditional way of thinking of cancer—one cancer gene to treat and you're done—is obviously not the best approach to treating this disease. These are complex, overlapping molecular pathways. Dissecting them and determining how to use that information to apply combinations of chemotherapeutic agents will allow for individualization of therapy," he adds.

Next year, Reed and his colleagues expect to begin testing the RB tumour suppressor in human tumour tissue samples from the UC Thoracic Tumour Registry and compare them to patients with known outcomes.

The findings of the study are published in the September 2007 issue of the journal Cancer Research.

Source: ANI
SRM/S
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
Long-Term Glycemic Control - A Better Measure of COVID-19 Severity
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Lung Biopsy Lung Cancer Cancer and Homeopathy Chronic Lymphocytic Leukemia Hodgkins Lymphoma Non-Hodgkins Lymphoma Chemotherapy Chemotherapy Drugs Cancer Facts Asbestosis 

Recommended Reading
Survival of Small–Cell Lung Cancer Increased By Prophylactic Cranial Irradiation
Prophylactic cranial irradiation performed after chemotherapy significantly reduces the risk of .....
Asbestosis
Asbestosis is a chronic inflammatory lung disease that occurs due to long term exposure to asbestos ...
Chemotherapy
‘Chemo’ means medicine or ‘drug’; ‘therapy’ means ‘treatment’. Chemotherapy refers to the use of cy...
Chemotherapy Drugs
Chemotherapy drugs perform like ‘magic bullets’ to destroy cancer cells in the body....
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL) is one of the most common types of adult leukemia and is consider...
Hodgkins Lymphoma
Hodgkins lymphoma or Hodgkins disease has the distinction of being the first cancer to be cured by c...
Lung Biopsy
The procedure by which tissue samples are obtained from the lung is known as lung biopsy. The biopsy...
Lung Cancer
Lung cancer is a malignant tumor in the lung tissues. Smoking is the main cause of lung cancer with ...
Non-Hodgkins Lymphoma
Non Hodgkins Lymphoma is a cancer that affects the lymph tissues. It is made up of a wide array of ....

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use